Biomerica, Inc. (BMRA) vs Enveric Biosciences, Inc. (ENVB)
A side-by-side comparison of Biomerica, Inc. and Enveric Biosciences, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BMRA
Biomerica, Inc.
$2.05HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
ENVB
Enveric Biosciences, Inc.
$1.51HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
Total return — BMRA vs ENVB
growth of $100 · dividends reinvested · last 10yBMRA -82.7% (-16.1%/yr)ENVB -100.0% (-75.0%/yr)BMRA compounded faster over this window
Log scale — wide-divergence pair
BMRA ENVB
BMRA vs ENVB: by the numbers
- •ENVB is the larger company ($7M vs $6M market cap).
- •Both run net losses; ENVB's is the smaller (0.00% vs -84.79% net margin).
Metrics side by side
Valuation
| Metric | BMRA | ENVB |
|---|---|---|
| P/S ratio | 1.42 | N/A |
| P/B ratio | 2.41 | 0.84 |
Profitability
| Metric | BMRA | ENVB |
|---|---|---|
| Gross margin | 8.09% | 0.00% |
| Operating margin | -119.54% | 0.00% |
| Net margin | -84.79% | 0.00% |
| ROE | -143.54% | -108.00% |
| ROIC | -117.93% | -107.99% |
Growth (annualized)
| Metric | BMRA | ENVB |
|---|---|---|
| Revenue CAGR (5Y) | -9.17% | N/A |
| Total return CAGR (5Y) | -46.66% | N/A |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.